Health & Biotech
ASX health stocks: EMV’s brain scanner is completed and ready for testing, stock price jumps 16pc
Health & Biotech
China’s consumable beauty market is set to explode, and ASX wellness stocks are hoping to benefit
Health & Biotech
ScoPo’s Powerplays: Smaller capped health stocks are still in ‘no man’s land’, but Neuren jumps 18pc this week
Health & Biotech
More resources, better vets, booming profits; How Apiam is changing the game with Australia’s largest regional vet network
Health & Biotech
ASX health stocks: dorsaVi leads the pack with 12% jump on major contract extension
Health & Biotech
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing
Health & Biotech
PharmAust’s subsidiary Epichem builds ‘world-first’ flow reactor to convert waste into fuel
Health & Biotech
ASX health stocks: Mayne Pharma slapped with lawsuit, Patrys encounters clinical trial delays
Health & Biotech
Dimerix’s flags acceleration of Phase 3 trials for its COVID-19 treatment in Europe
Health & Biotech
ASX Cannabis Stocks: Creso pops on 450pc annual revenue increase
Health & Biotech
ASX Health Stocks: Hydrix implants world’s first Guardian heart attack alert system
Health & Biotech
Apiam is staying busy in M&A as it builds a dominant regional vet network – here’s how the numbers stack up
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.